Concepedia

T. Kato

TK

Statistics

Publications

2

Citations

40

H-Index

2

Active since

2021

Affiliations

Kanagawa Cancer Center(Current)

Kanagawa Prefectural Hospital Organization

National Cancer Center Hospital East

T. Kato is an author at Kanagawa Cancer Center specializing in non-small cell lung cancer therapy, cancer pharmacology, and malignant neoplasms.

Publications per year

2021–2022

2

Publications

2

LBA47 Osimertinib as adjuvant therapy in patients (pts) with resected EGFR-mutated (EGFRm) stage IB-IIIA non-small cell lung cancer (NSCLC): Updated results from ADAURA

Masahiro Tsuboi, Yi‐Long Wu, C Grohé et al. · Annals of Oncology · 2022 · 23 citations

, , +14

LBA44 Primary results of a randomized phase II study of osimertinib plus bevacizumab versus osimertinib monotherapy for untreated patients with non-squamous non-small cell lung cancer harboring EGFR mutations: WJOG9717L study

Hirotsugu Kenmotsu, Kazushige Wakuda, Keita Mori et al. · Annals of Oncology · 2021 · 17 citations

, , +14

1–2 of 2